Skip to main content
 

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member Company was granted an unique dual clearance from the FDA for the AI detection of
life-threatening cardiac conditions, including heart attacks.

Learn more here.

More News

  • Artificial Intelligence in the Clinic: Don’t Pay for the Tool, Pay for the Care

  • Brainomix Extends Series C Financing to $25.4M to Support U.S. Expansion

  • Dr. Eric Topol’s mentions CureMetrix: All Mammograms Should Incorporate A.I. | CureMetrix